NDC 70710-1699-2 - Venlafaxine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70710-1699
- Requested NDC
- 70710-1699-2
- Package NDCs from labels
- 70710-1699-5, 70710-1699-0, 70710-1699-2, 70710-1699-4, 70710-1699-3, 70710-1699-9
- Manufacturer
- Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited
- Effective date
- 2026-01-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| VENLAFAXINE - Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 2026-01-12 | HUMAN PRESCRIPTION DRUG LABEL |
| Venlafaxine Hydrochloride - REMEDYREPACK INC. | REMEDYREPACK INC. | 2024-05-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70710-1699-0 | Venlafaxine Hydrochloride | 1000 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 1000 | 3 | |
| 70710-1699-2 | Venlafaxine Hydrochloride | 10 in 1 BLISTER PACK | CAPSULE, EXTENDED RELEASE | 10 | 3 | |
| 70710-1699-3 | Venlafaxine Hydrochloride | 30 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 30 | 3 | |
| 70710-1699-4 | Venlafaxine Hydrochloride | 10 in 1 CARTON | CAPSULE, EXTENDED RELEASE | 10 | 3 | |
| 70710-1699-5 | Venlafaxine Hydrochloride | 500 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 500 | 3 | |
| 70710-1699-9 | Venlafaxine Hydrochloride | 90 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 90 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70710-1699 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS USA INC.] | 2 | Current NDC, 6 package rows | 20230905_9fda0f8d-b24e-4581-9dca-7aaaf86e2413.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70710-1699-0 | EA - Each | 70710-1699 | 8f29174b-5928-46b7-87bf-6db9cce308f7 | 1 | 2024-04-05 |
| 70710-1699-9 | EA - Each | 70710-1699 | cea40c4a-925a-4aa8-8a92-9bc90ac71944 | 1 | 2024-04-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Calamine | FERRIC OXIDE RED | Perrigo Direct, Inc | 256bd1d4-fd50-408f-9aee-84f218bb4971 | 2026-02-19 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXIND HCL | Perrigo Direct, Inc | 54a20ec9-ab86-4410-af94-e04393e9d4b3 | 2026-02-19 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXINE HCL | Meijer, Inc. | 6b369ef2-fd54-4931-a9eb-0fb42834c2ef | 2026-02-19 | Warnings, Adverse reactions | 1K09F3G675 |
| Allay Skin Solutions Protect Nourish Mineral Sunscreen SPF 42 | TITANIUM DIOXIDE, ZINC OXIDE | ALLAY SKIN SOLUTIONS LLC | 425bf1d7-f2cf-4237-9047-dd53054acd1c | 2026-02-18 | Warnings | 15FIX9V2JP |
| Calamine | FERRIC OXIDE RED | Target Corporation | d4ee05c8-ae62-45df-8783-1ed57fa030ec | 2026-02-18 | Warnings, Adverse reactions | 1K09F3G675 |
| Hermes Plein Air-Baume de Teint Perfecteur Naturel-Enhancing Complexion Balm 85 TAMARIN | TITANIUM DIOXIDE | S.A. COMPTOIR NOUVEAU DE LA PARFUMERIE | dacff3dc-49d7-6416-e053-2a95a90a85c6 | 2026-02-18 | Warnings | 15FIX9V2JP |
| Calamine | FERRIC OXIDE RED | Topco Associates LLC | 2b32e720-ac71-4d60-bc06-e28a00f8a450 | 2026-02-13 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXINE HCL | Topco Associates LLC | 15d1ae3f-509c-4e6b-8f0c-cf9265680358 | 2026-02-13 | Warnings, Adverse reactions | 1K09F3G675 |
| Venlafaxine | VENLAFAXINE | Sun Pharmaceutical Industries, Inc. | 55889b3d-74c9-4638-9a14-6a4ca3a99f7f | 2026-02-11 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| venlafaxine | VENLAFAXINE HYDROCHLORIDE | REMEDYREPACK INC. | ddb51556-0292-4aa9-b781-a402c912591f | 2026-02-10 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Alumier MD Clear Shield Broad Spectrum SPF 42 Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Alumier Labs | a9c970c8-b6e3-b0a1-e053-2a95a90a89c7 | 2026-02-09 | Warnings | 15FIX9V2JP |
| Droptics Performance Eye Drops | NAPHAZOLINE HYDROCHLORIDE, PROPYLENE GLYCOL | Droptics LLC | 20fd6822-a7fd-4593-92bb-0a07260893e2 | 2026-02-09 | Warnings | 6DC9Q167V3 |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Bryant Ranch Prepack | d7d1319c-500e-4ca0-83a1-a739cfa01cf7 | 2026-02-09 | Boxed warning, Warnings, Adverse reactions | 313583 7D7RX5A8MO |
| Hampton Sun SPF 50 Mineral | ZINC OXIDE 19.5% TITANIUM DIOXIDE 4.00% | S&C Hampton Sun LLC | d6c33436-042e-44e8-8b55-98be6e246879 | 2026-02-06 | Warnings | 15FIX9V2JP |
| SHISEIDO WASO COLOR-SMART DAY MOISTURIZER | OCTINOXATE, TITANIUM DIOXIDE | Shiseido Americas Corporation | f291f077-1c72-48fc-bb19-c20bdeaaa596 | 2026-02-06 | Warnings | 15FIX9V2JP |
| SHISEIDO WASO COLOR-SMART DAY MOISTURIZER | OCTINOXATE, TITANIUM DIOXIDE | Shiseido Americas Corporation | 54f63dd8-e77f-42e4-a6d3-61ab7beecf50 | 2026-02-06 | Warnings | 15FIX9V2JP |
| SEYTU Body Sunscreen | TITANIUM DIOXIDE AND ZINC OXIDE | Omnilife USA, Inc. | c411e9a6-b2ea-446b-a886-b92c61736e6c | 2026-02-05 | Warnings | 15FIX9V2JP |
| SEYTU Facial Sunscreen | TITANIUM DIOXIDE AND ZINC OXIDE | Omnilife USA, Inc. | 96fd37fb-c3ff-413f-b2c8-50754f320ecc | 2026-02-05 | Warnings | 15FIX9V2JP |
| Venlafaxine | VENLAFAXINE | REMEDYREPACK INC. | 570beece-6f30-4850-a3bc-636e7cf8d423 | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Bamboo | OCTINOXATE, TITANIUM DIOXIDE | BCM Cosmetique SAS | ebfe03e7-614f-44b1-b1f1-78edc7e274cc | 2026-02-05 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.